75 participants
Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-12-11
- Start Date:
- 2023-12-01
- Completion:
- 2025-10-31
Conditions
- Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Interventions
- DRUG
No Results Yet